Each year, thousands of infants begin a silent unraveling — vision dimming, limbs weakening, seizures arriving without warning — as the molecular scaffolding their developing brains depend upon fails to form. Researchers at UC Davis have now mapped, with atomic precision, the protein machinery responsible for this failure in rare genetic disorders known as chaperone tubulinopathies, revealing not only why these children's neurons cannot wire themselves correctly, but what a future therapy would need to repair. The discovery, built across two landmark papers and years of families searching for
Scientists map cellular mechanism in rare childhood brain disorders
Thousands of infants annually develop severe neurological decline including seizures, weakness, and breathing problems with life-shortening consequences and no available treatments.
We have a precise picture of exactly what's going wrong
Mark
Why does it matter that we can now see these proteins in nine different configurations instead of just one?
Mimi
Because the disease isn't about a broken machine sitting still—it's about a machine that can't move through its cycle. Seeing nine snapshots is like watching a film frame by frame instead of a still photograph. You understand what it's supposed to do, and you can see exactly where the mutation jams it up.
Mark
So when a parent asks about gene therapy, what would that actually look like?
Mimi
Right now, it's still theoretical. But if you could repair the mutated gene or replace the broken protein, you'd restore the cell's ability to make tubulin dimers. The microtubules would form again. The neurons could grow. That's the hope.
Mark
How many children are we talking about?
Mimi
Thousands per year develop these specific disorders. But Al-Bassam thinks many more children with unexplained neurological problems might have small mutations in these genes that nobody's caught yet. The real number could be much larger.
Mark
Why did this research stall for so long?
Mimi
The proteins were incredibly difficult to study with older technology. You couldn't see them clearly enough to understand how they worked. Cryo-electron microscopy changed that—it lets you freeze proteins in their natural state and photograph them at near-atomic resolution. Suddenly, what was invisible became visible.
Mark
What happens to a child with one of these disorders right now, today?
Mimi
Seizures, weakness, breathing problems. The brain structures don't develop properly. These are life-shortening diseases. There's no treatment. Parents get a diagnosis and then they wait. Now, at least, there's a map. There's something to work toward.
O Pulso
- Thousands of infants each year enter a medical labyrinth of seizures, weakening limbs, and fading cognition, carrying diagnoses that explain little and offer nothing in the way of treatment.
- The culprit is a failure deep inside the cell: mutated chaperone proteins that can no longer assemble the microtubule building blocks neurons need to grow, connect, and sustain a developing brain.
- For decades the field stalled — these proteins were too elusive to study — until a UC Davis team used cryo-electron microscopy to freeze them mid-action and photograph their inner workings at atomic resolution.
- Two papers published six months apart have now revealed the full assembly cycle of this molecular machinery, exposing precisely where mutations strike and what any future gene therapy would need to correct.
- The most immediate gain may be speed: families currently lost in years-long diagnostic odysseys could reach answers in months, and children with unexplained neurological disorders may finally find their conditions named.
Each year, thousands of infants begin a silent unraveling — vision dimming, limbs weakening, seizures arriving without warning — as the molecular scaffolding their developing brains depend upon fails to form. Researchers at UC Davis have now mapped, with atomic precision, the protein machinery responsible for this failure in rare genetic disorders known as chaperone tubulinopathies, revealing not only why these children's neurons cannot wire themselves correctly, but what a future therapy would need to repair. The discovery, built across two landmark papers and years of families searching for answers, transforms a biological mystery into a legible problem — and legible problems, in time, become solvable ones.
Every year, thousands of families watch the same quiet collapse unfold: a healthy infant begins to fade, losing eye contact, then movement, then the ability to breathe without struggle. By the time these parents reach Jawdat Al-Bassam's lab at UC Davis, they have already traveled a long road of inconclusive tests and devastating diagnoses — conditions grouped under the name chaperone tubulinopathies, rare genetic disorders with no treatments and no clear path forward. "I've gotten emails from folks all over the world," Al-Bassam said. "The parents are asking if there's a way to do gene therapy."
The disorders strike at something fundamental. Inside every developing neuron, structures called microtubules form the scaffolding that allows brain cells to grow long extensions, reach across hemispheres, and connect the mind to the body. These microtubules are assembled from paired protein units, and the pairing process depends on specialized chaperone proteins that capture, match, and release the components in a precise molecular choreography. When mutations damage the genes encoding these chaperones, the supply of building blocks collapses — and even a small shortfall is enough to derail a brain still learning to wire itself.
Scientists had known for decades that mutations in these genes caused disease, but the proteins resisted study and the field stalled. The breakthrough came through cryo-electron microscopy, which allowed Al-Bassam's team — led in part by undergraduate researcher Aryan Taheri — to freeze the proteins mid-action and photograph them at atomic resolution. A December 2025 paper in Nature Communications revealed a spring-and-latch mechanism the chaperones use to assemble their cargo. "This was a surprise," Al-Bassam said. "It was really beautiful."
A follow-up paper in Science Advances, published in May 2026, captured the molecular machine across at least nine configurations, tracing the complete assembly and disassembly cycle and showing, for the first time, exactly where mutations intervene. "We have a precise picture of exactly what's going wrong, and what a future therapy would need to fix," Al-Bassam said.
The most immediate consequence may be diagnostic. Families today endure what clinicians call a diagnostic odyssey — genome sequencing, inconclusive results, years without answers. A clearer map of how these mutations disrupt function could compress that journey from years to months. Further out lies the possibility of gene therapy, and further still, the recognition that many children currently labeled with unexplained neurological disorders may carry small mutations in these same genes, waiting to be found.
Every year, thousands of families experience the same rupture: a baby who seemed perfectly healthy begins to fade. The smiling stops. Eye contact vanishes. Limbs weaken. Seizures come. Breathing becomes difficult. By the time these parents find their way to Jawdat Al-Bassam's lab at UC Davis, they have already spent months or years in a medical maze, collecting devastating diagnoses for conditions with names like infantile encephalopathy and Kenny-Caffey syndrome. These are chaperone tubulinopathies—rare genetic disorders with no treatments, no cures, no clear path forward. "I've gotten emails from folks all over the world," Al-Bassam said. "The parents are asking if there's a way to do gene therapy."
For decades, the answer was no. But in two papers published within six months of each other—one in December 2025 and another in May 2026—Al-Bassam's team has mapped the precise molecular machinery that breaks down in these children's cells. The discovery could reshape how these diseases are understood, diagnosed, and eventually treated.
At the heart of the problem are structures called microtubules, which form protein scaffolds inside every cell. In the developing brain, microtubules are essential. They guide neurons as they grow long, thread-like extensions called axons that reach across the brain and down the spinal cord, connecting the eyes to the visual cortex, linking the left and right hemispheres, and extending into the arms, legs, and lungs. Without properly formed microtubules, a baby's neurons cannot wire themselves correctly. Vision fails. Cognition falters. Coordination collapses. Breathing becomes impossible.
Microtubules are built from two proteins—alpha-tubulin and beta-tubulin—that must be snapped together into paired units called dimers before they can assemble into the larger structures. This assembly process is controlled by special proteins called tubulin cofactors, which act like molecular cages. When a cell produces beta-tubulin, a cofactor wraps around it and holds it secure until an alpha-tubulin arrives. The two proteins snap together, and the cofactor releases the completed dimer. It is a delicate choreography. When it fails—when mutations damage the cofactor genes—the cell's supply of dimers plummets. Even a small decrease is toxic to developing neurons. The microtubules cannot form. The brain does not develop.
Scientists identified mutations in tubulin cofactor genes decades ago, first in yeast thirty-five years ago, then in humans fifteen years later. But the proteins were difficult to study, and the field stalled. The breakthrough came when Al-Bassam's team, led by undergraduate researcher Aryan Taheri, used cryo-electron microscopy to freeze these proteins in action and photograph them at atomic resolution. In the December paper, published in Nature Communications, they revealed the spring-and-latch mechanism the cofactors use to capture, pair, and release the tubulin dimers. "This was a surprise," Al-Bassam said. "It was really beautiful."
The May paper, published in Science Advances, went further. The team captured the molecular machine in at least nine different configurations, revealing the complete cycle of how it assembles dimers when needed and disassembles them when it does not. For the first time, scientists could see exactly what goes wrong when mutations strike. "We have a precise picture of exactly what's going wrong, and what a future therapy would need to fix," Al-Bassam said.
The immediate impact may be diagnostic. Families currently endure what doctors call a diagnostic odyssey—sequencing genomes, chasing inconclusive results, searching for answers that never come. With a clear understanding of how tubulin cofactor mutations disrupt function, doctors could identify these disorders faster. Children could be diagnosed in months instead of years. Beyond that lies the possibility of gene therapy, the question Al-Bassam hears from desperate parents around the world. And beyond that lies something larger: the recognition that many children born with unexplained neurological problems may carry small mutations in these same genes. Finding them would be, Al-Bassam said, "a huge step forward."
Citações Notáveis
I've gotten emails from folks all over the world. The parents are asking if there's a way to do gene therapy.— Jawdat Al-Bassam, UC Davis
For the first time, we have a precise picture of exactly what's going wrong, and what a future therapy would need to fix.— Jawdat Al-Bassam, UC Davis
Quer a matéria completa?
Leia o original em News-Medical.net ↗
Education